{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:49:03Z","timestamp":1790344143236,"version":"4.1.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16fk0108102"],"award-info":[{"award-number":["16fk0108102"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16fk0108102"],"award-info":[{"award-number":["16fk0108102"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17fk0108202"],"award-info":[{"award-number":["17fk0108202"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17fk0108202"],"award-info":[{"award-number":["17fk0108202"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18fk0108102"],"award-info":[{"award-number":["18fk0108102"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18fk0108102"],"award-info":[{"award-number":["18fk0108102"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["16K09935"],"award-info":[{"award-number":["16K09935"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["19K08931"],"award-info":[{"award-number":["19K08931"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Severe fever with thrombocytopenia syndrome (SFTS) is a bunyavirus infection with high mortality. Favipiravir has shown effectiveness in preventing and treating SFTS virus (SFTSV) infection in animal models. A multicenter non-randomized, uncontrolled single arm trial was conducted to collect data on the safety and the effectiveness of favipiravir in treatment of SFTS patients. All participants received favipiravir orally (first-day loading dose of 1800 mg twice a day followed by 800 mg twice a day for 7\u201314 days in total). SFTSV RT-PCR and biochemistry tests were performed at designated time points. Outcomes were 28-day mortality, clinical improvement, viral load evolution, and adverse events (AEs). Twenty-six patients were enrolled, of whom 23 were analyzed. Four of these 23 patients died of multi-organ failure within one week (28-day mortality rate: 17.3%). Oral favipiravir was well tolerated in the surviving patients. AEs (abnormal hepatic function and insomnia) occurred in about 20% of the patients. Clinical symptoms improved in all patients who survived from a median of day 2 to day10. SFTSV RNA levels in the patients who died were significantly higher than those in the survivors (p = 0.0029). No viral genomes were detectable in the surviving patients a median of 8 days after favipiravir administration. The 28-day mortality rate in this study was lower than those of the previous studies in Japan. The high frequency of hepatic dysfunction as an AE was observed. However, it was unclear whether this was merely a side effect of favipiravir, because liver disorders are commonly seen in SFTS patients. The results of this trial support the effectiveness of favipiravir for patients with SFTS.<\/jats:p>","DOI":"10.1371\/journal.pntd.0009103","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T13:22:51Z","timestamp":1614000171000},"page":"e0009103","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":79,"title":["A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9154-0162","authenticated-orcid":true,"given":"Koichiro","family":"Suemori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-7298","authenticated-orcid":true,"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4025-8650","authenticated-orcid":true,"given":"Atsushi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Himeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4181-0566","authenticated-orcid":true,"given":"Takashi","family":"Haku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinatsu","family":"Kamikokuryo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kakihana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuto","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5912-0208","authenticated-orcid":true,"given":"Toru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9097-5861","authenticated-orcid":true,"given":"Akitsugu","family":"Furumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9918-5970","authenticated-orcid":true,"given":"Toshiyuki","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6639-3159","authenticated-orcid":true,"given":"Masahiko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6473-800X","authenticated-orcid":true,"given":"Norimitsu","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetoshi","family":"Sakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6392-3767","authenticated-orcid":true,"given":"Tomohiro","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7267-9823","authenticated-orcid":true,"given":"Hiroki","family":"Ohge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kurosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7601-4036","authenticated-orcid":true,"given":"Tomoki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5745-8413","authenticated-orcid":true,"given":"Masayuki","family":"Shimojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1538-433X","authenticated-orcid":true,"given":"Masaki","family":"Yasukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"pntd.0009103.ref001","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"XJ Yu","year":"2011","journal-title":"N Engl J Med"},{"key":"pntd.0009103.ref002","doi-asserted-by":"crossref","first-page":"e1002369","DOI":"10.1371\/journal.ppat.1002369","article-title":"Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus","volume":"7","author":"B Xu","year":"2011","journal-title":"PLoS Pathog"},{"key":"pntd.0009103.ref003","first-page":"1892","article-title":"Severe fever with thrombocytopenia syndrome, South Korea, 2012","volume":"19","author":"KH Kim","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009103.ref004","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/infdis\/jit603","article-title":"The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan","volume":"209","author":"T Takahashi","year":"2014","journal-title":"J Infect Dis"},{"key":"pntd.0009103.ref005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-981-13-9562-8_13","volume-title":"Severe fever with thrombocytopenia syndrome","author":"M. Saijo","year":"2019"},{"key":"pntd.0009103.ref006","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7883\/yoken.JJID.2018.526","article-title":"A case of cat-to-human transmission of severe fever with thrombocytopenia syndrome virus","volume":"72","author":"K Kida","year":"2019","journal-title":"Jpn J Infect Dis"},{"key":"pntd.0009103.ref007","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/22221751.2019.1710436","article-title":"The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan","volume":"9","author":"TL Lin","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"7","key":"pntd.0009103.ref008","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3201\/eid2607.200104","article-title":"Human case of severe fever with thrombocytopenia syndrome virus infection, Taiwan, 2019","volume":"26","author":"SH Peng","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009103.ref009","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3201\/eid2505.181463","article-title":"Endemic severe fever with thrombocytopenia syndrome, Vietnam","volume":"25","author":"XC Tran","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009103.ref010","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3201\/eid2110.141928","article-title":"Characteristics and factors associated with death among patients hospitalized for severe fever with thrombocytopenia syndrome, South Korea. 2013","volume":"21","author":"J Shin","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009103.ref011","doi-asserted-by":"crossref","first-page":"e0165207","DOI":"10.1371\/journal.pone.0165207","article-title":"Epidemiological and clinical features of severe fever with thrombocytopenia syndrome in Japan, 2013\u20132014","volume":"11","author":"H Kato","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"pntd.0009103.ref012","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3201\/eid2604.191011","article-title":"Epidemiological study of severe fever with thrombocytopenia syndrome in Japan, 2013\u20132017","volume":"26","author":"Y Kobayashi","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009103.ref013","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011\u201317: a prospective observational study","volume":"18","author":"H Li","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"pntd.0009103.ref014","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4269\/ajtmh.16-0251","article-title":"Epidemiological and clinical features of severe fever with thrombocytopenia syndrome during an outbreak in South Korea, 2013\u20132015","volume":"95","author":"SW Park","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009103.ref015","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1128\/JCM.00742-14","article-title":"Sensitive and specific PCR systems for detection of both Chinese and Japanese severe fever with thrombocytopenia syndrome virus strains and prediction of patient survival based on viral load","volume":"52","author":"T Yoshikawa","year":"2015","journal-title":"J Clin Microbiol"},{"key":"pntd.0009103.ref016","doi-asserted-by":"crossref","first-page":"89119","DOI":"10.18632\/oncotarget.19163","article-title":"Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis","volume":"8","author":"Y Chen","year":"2017","journal-title":"Oncotarget"},{"key":"pntd.0009103.ref017","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jiac.2017.11.004","article-title":"Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome","volume":"24","author":"S Nakamura","year":"2018","journal-title":"J Infect Chemother"},{"key":"pntd.0009103.ref018","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3349\/ymj.2017.58.4.867","article-title":"Effect of early plasma exchange on survival in patients with severe fever with thrombocytopenia syndrome: a multicenter study","volume":"58","author":"WS Oh","year":"2017","journal-title":"Yonsei Med J"},{"issue":"4","key":"pntd.0009103.ref019","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Y Furuta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0009103.ref020","doi-asserted-by":"crossref","first-page":"e00061","DOI":"10.1128\/mSphere.00061-15","article-title":"Efficacy of T-705 (favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus","volume":"1","author":"H Tani","year":"2016","journal-title":"mSphere"},{"key":"pntd.0009103.ref021","doi-asserted-by":"crossref","first-page":"e0206416","DOI":"10.1371\/journal.pone.0206416","article-title":"Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in al lethal mouse model: dose-efficacy studies upon oral administration","volume":"13","author":"H Tani","year":"2018","journal-title":"PLoS One"},{"key":"pntd.0009103.ref022","doi-asserted-by":"crossref","first-page":"e01942","DOI":"10.1128\/JVI.01942-16","article-title":"Modeling severe fever with thrombocytopenia syndrome virus infection in golden Syrian hamsters: Importance of STAT2 in preventing disease and effective treatment with favipiravir","volume":"91","author":"BB Gowen","year":"2017","journal-title":"J Virol"},{"key":"pntd.0009103.ref023","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/d41586-018-04486-6","article-title":"East Asia braces for surge in deadly tick-borne virus","volume":"556","author":"D. Cyranoski","year":"2018","journal-title":"Nature"},{"key":"pntd.0009103.ref024","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update","volume":"53","author":"J Bruix","year":"2011","journal-title":"Hepatology"},{"key":"pntd.0009103.ref025","unstructured":"Ministry of Health, Labour, and Welfare of Japan. Criteria for seriousness classification of adverse drug reactions (PAB\/SD Notification No. 80) issued by the Director of Safety Division, Pharmaceutical Affairs Bureau on June 29, 1992. Available from: https:\/\/www.mhlw.go.jp\/content\/11121000\/000529049.pdf., (accessed on 13rd July, 2020, in Japanese)."},{"key":"pntd.0009103.ref026","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jiac.2018.07.009","article-title":"Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy","volume":"24","author":"M. Saijo","year":"2018","journal-title":"J Infect Chemother"},{"key":"pntd.0009103.ref027","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3349\/ymj.2019.60.6.592","article-title":"Higher fatality for severe fever with thrombocytopenia syndrome complicated by hemophagocytic lymphohistiocytosis","volume":"60","author":"IY Jung","year":"2019","journal-title":"Yonsei Med J"},{"key":"pntd.0009103.ref028","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2018.01.017","article-title":"Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome","volume":"101","author":"JS Kwon","year":"2018","journal-title":"J Clin Virol"},{"key":"pntd.0009103.ref029","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/infdis\/jis452","article-title":"Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome","volume":"206","author":"Y Sun","year":"2012","journal-title":"J Infect Dis"},{"key":"pntd.0009103.ref030","unstructured":"National Institute of Infectious Diseases. Summary of severe fever with thrombocytopenia syndrome cases reported to the National Epidemiological Surveillance of Infectious Diseases. Available from: https:\/\/www.niid.go.jp\/niid\/ja\/sfts\/sfts-idwrs\/7415-sfts-nesid.html, (accessed on 14th November, 2020, in Japanese)."},{"key":"pntd.0009103.ref031","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Y Furuta","year":"2013","journal-title":"Antivir Res"},{"key":"pntd.0009103.ref032","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/cid\/cit100","article-title":"Epidemiologic features of severe fever with thrombocytopenia syndrome in China, 2011\u20132012","volume":"56","author":"F Ding","year":"2013","journal-title":"Clin Infect Dis"},{"key":"pntd.0009103.ref033","first-page":"209","article-title":"Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China","volume":"32","author":"YZ Zhang","year":"2011","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"pntd.0009103.ref034","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/infdis\/jis472","article-title":"Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients","volume":"206","author":"ZT Gai","year":"2012","journal-title":"J Infect Dis"},{"key":"pntd.0009103.ref035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijid.2013.08.011","article-title":"Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome","volume":"18","author":"WS Oh","year":"2014","journal-title":"Int J Infect Dis"},{"key":"pntd.0009103.ref036","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3947\/ic.2017.49.1.72","article-title":"Two treatment cases of severe fever and thrombocytopenia syndrome with oral ribavirin and plasma exchange","volume":"49","author":"I Park","year":"2017","journal-title":"Infect Chemother"},{"key":"pntd.0009103.ref037","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cid\/cit530","article-title":"Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in China who had severe fever with thrombocytopenia syndrome","volume":"57","author":"W Liu","year":"2013","journal-title":"Clin Infect Dis"},{"key":"pntd.0009103.ref038","unstructured":"Fjujifilm Toyama Chemical Co., Ltd. Package insert for favipiravir tablet for the usage for patients with influenza virus infection. Available from: https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/400022_625004XF1022_2_02 (accessed on 16th November, 2020, in Japanese)."},{"key":"pntd.0009103.ref039","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7883\/yoken.JJID.2015.404","article-title":"Ulcerative lesions with hemorrhage in a patient with severe fever with thrombocytopenia syndrome observed via upper gastrointestinal endoscopy","volume":"69","author":"S Kaneyuki","year":"2016","journal-title":"Jpn J Infect Dis"},{"key":"pntd.0009103.ref040","first-page":"295","article-title":"Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705)","volume":"48","author":"R Song","journal-title":"Infection. 2020"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T13:23:54Z","timestamp":1614000234000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009103"}},"subtitle":[],"editor":[{"given":"Nam-Hyuk","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009103","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]}}}